SEPTANEST

This brand name is authorized in Austria, Canada, Cyprus, Ecuador, Estonia, Spain, France, Hong Kong, Croatia, Lithuania, Malta, Netherlands, New Zealand, Poland, Romania, Tunisia, United Kingdom, South Africa

Active ingredients

The drug SEPTANEST contains a combination of these active pharmaceutical ingredients (APIs):

1 Articaine UNII QS9014Q792 - ARTICAINE HYDROCHLORIDE

Articaine is a local anaesthetic of the amide type. Preclinical pharmacodynamic studies show that the mechanism of action of articaine is similar to that of other commonly used anaesthetics. Read about Articaine

2 Epinephrine UNII 30Q7KI53AK - EPINEPHRINE BITARTRATE

Epinephrine is a direct acting sympathomimetic agent, which exerts effects on both α and β adrenoceptors. It has more pronounced effects on β than on α adrenoceptors, although α effects prevail at high doses. The effects of adrenaline include increased rate and force of cardiac contraction, cutaneous vasoconstriction and broncho-dilatation. Read about Epinephrine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N01BB58	Articaine, combinations	N Nervous system → N01 Anesthetics → N01B Anesthetics, local → N01BB Amides
Discover more medicines within N01BB58

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02123371, 02123398
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 23.384-1-05-11, 360390512
Country: EE	Ravimiamet	Identifier(s): 1010967, 1010978, 1818176, 1818187, 1818198, 1818200
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 59941, 59942
Country: FR	Base de données publique des médicaments	Identifier(s): 60484221, 69208046
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 211428, 326399
Country: HK	Department of Health Drug Office	Identifier(s): 58946
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-142112354, HR-H-649485270
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1012964, 1089456, 1089457, 1089458, 1089459, 1089460, 1089461
Country: MT	Medicines Authority	Identifier(s): MA035/00201, MA035/00202
Country: NL	Z-Index G-Standaard	Identifier(s): 14785196, 14785218
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 145890, 145904
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 11837, 21325, 21504
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100060602, 100060619
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W05650001, W05650002, W05650003, W05650004, W10707001, W10707002, W10707003, W10707004
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 8533013, 8533014
Country: ZA	Health Products Regulatory Authority	Identifier(s): A38/4/0412